These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25218916)

  • 1. Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings.
    Navas-Carrillo D; Ríos A; Rodríguez JM; Parrilla P; Orenes-Piñero E
    Biochim Biophys Acta; 2014 Dec; 1846(2):468-76. PubMed ID: 25218916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer.
    Vriens MR; Suh I; Moses W; Kebebew E
    Thyroid; 2009 Dec; 19(12):1343-9. PubMed ID: 20001717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.
    Sippel RS; Caron NR; Clark OH
    World J Surg; 2007 May; 31(5):924-33. PubMed ID: 17429563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial nonmedullary thyroid cancer: a review of the genetics.
    Khan A; Smellie J; Nutting C; Harrington K; Newbold K
    Thyroid; 2010 Jul; 20(7):795-801. PubMed ID: 20465534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Management of Hereditary Thyroid Cancer.
    Bano G; Hodgson S
    Recent Results Cancer Res; 2016; 205():29-44. PubMed ID: 27075347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on familial nonmedullary thyroid cancer.
    Ammar SA; Alobuia WM; Kebebew E
    Endocrine; 2020 Jun; 68(3):502-507. PubMed ID: 32162184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
    Moses W; Weng J; Kebebew E
    Thyroid; 2011 Apr; 21(4):367-71. PubMed ID: 21190444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study.
    Robenshtok E; Tzvetov G; Grozinsky-Glasberg S; Shraga-Slutzky I; Weinstein R; Lazar L; Serov S; Singer J; Hirsch D; Shimon I; Benbassat C
    Thyroid; 2011 Jan; 21(1):43-8. PubMed ID: 20954815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
    Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
    Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors.
    Cirello V
    Minerva Endocrinol (Torino); 2021 Mar; 46(1):5-20. PubMed ID: 33045820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial nonmedullary thyroid carcinoma.
    Mazeh H; Sippel RS
    Thyroid; 2013 Sep; 23(9):1049-56. PubMed ID: 23734600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.
    Bauer AJ
    Front Horm Res; 2013; 41():141-8. PubMed ID: 23652675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features of familial nonmedullary thyroid carcinoma.
    Fan YF; Zhang B; Yang X; Shang ZH; Liu HF; Xie Y; Liu YW; Gao WS; Wu Q; Li XY
    Chin Med J (Engl); 2015 Apr; 128(8):1037-41. PubMed ID: 25881596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
    Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
    Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial nonmedullary thyroid cancer].
    Sugino K; Mimura T; Ito K; Ito K
    Nihon Rinsho; 2000 Jul; 58(7):1519-22. PubMed ID: 10921335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and biological features of familial nonmedullary thyroid carcinoma].
    Gao J; Yu Y; Li X; Zhao J; Zhao C; Zhao J; Liu Y; Li Y; Gao M
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):202-6. PubMed ID: 24785281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.
    Park YJ; Ahn HY; Choi HS; Kim KW; Park DJ; Cho BY
    Thyroid; 2012 Apr; 22(4):356-62. PubMed ID: 22280228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
    Zhang T; Xing M
    J Natl Cancer Inst; 2016 Jun; 108(6):djv415. PubMed ID: 26832773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma.
    Uchino S; Noguchi S; Yamashita H; Murakami T; Watanabe S; Ogawa T; Tsuno A; Shuto S
    World J Surg; 2004 Nov; 28(11):1099-102. PubMed ID: 15490050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.